Cat.#: ACPP-1295
| Despition | Aspartate Beta-Hydroxylase Human Recombinant |
| SIZE | 5 µg |
| Purity | > 90.0% (SDS-PAGE) |
| Form | Sterile Filtered colorless solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1224 | LAMP1 Blocking Peptide (AC1224) | 250 µg | inquiry |
| ACPP-1412 | Human SLC4A4 Protein (AC1412) | 5 µg | inquiry |
| ACPP-1085 | Recombinant Human alpha Internexin Protein (AC1085) | 25 µl | inquiry |
| ACPP-1308 | TrkA Blocking Peptide (AC1308) | 250 µg | inquiry |
| ACPP-1379 | Human OLFM1 Protein (AC1379) | 2 µg | inquiry |
| ACPP-1139 | Recombinant Human Cadherin 10 Protein (6×His Tag) (AC1139) | 50 µg | inquiry |
| ACPP-1289 | Usherin Blocking Peptide (AC1289) | 250 µg | inquiry |
| ACPP-1071 | Visfatin Blocking Peptide (AC1071) | 250 µg | inquiry |
| ACPP-1463 | Human BCL2L11 Protein (AC1463) | 2 µg | inquiry |
| ACPP-1780 | Human DYRK1A Protein (AC1780) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.